Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 18;14(6):642.
doi: 10.3390/diagnostics14060642.

The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome

Stefano Sanduzzi Zamparelli  1 , Vincenzo Fucci  2 , Gaetano Rea  3 , Francesco Perna  2 , Marialuisa Bocchino  2 , Alessandro Sanduzzi Zamparelli  2   4
Affiliations

The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome

Stefano Sanduzzi Zamparelli et al. Diagnostics (Basel). .

Abstract

Background: The COVID-19 pandemic caused by SARS-CoV-2 continues to pose a significant threat worldwide, with severe cases leading to hospitalization and death. This study aims to evaluate the potential use of serum nucleocapsid antigen (NAg) and Krebs von den Lungen-6 glycoprotein (KL-6) as biomarkers of severe COVID-19 and to investigate their correlation with clinical, radiological, and biochemical parameters.

Methods: This retrospective study included 128 patients with confirmed SARS-CoV-2 infection admitted to a Neapolitan hospital in Italy between October 2020 and July 2021. Demographic, clinical, and laboratory data were collected, including serum levels of NAg and KL-6. The Chung et al. Computed Tomography Severity Score (TSS) was used to assess the severity of pneumonia, and outcomes were classified as home discharge, rehabilitation, and death. Statistical analyses were performed to compare Group I (home discharge and rehabilitation) and Group II (death, sub-intensive care, and ICU stay) based on demographic data, laboratory parameters, and TSS.

Results: Group II patients showed worse outcomes with higher levels of NAg, KL-6, and inflammatory markers, including interleukin-6 (IL-6), interleukin-2 receptor (IL-2R), and adrenomedullin. TSS was also significantly higher in Group II, with a positive correlation between TSS and NAg and KL-6 levels. Group I patients had higher values of hemoglobin (Hb) and platelets (PLT), while Group II patients had higher values of C-reactive protein (CRP), procalcitonin (PCT), D-Dimer, and glycemia. No significant difference was observed in gender distribution.

Conclusions: Serum NAg and KL-6 levels are potential biomarkers of severe COVID-19 pneumonia, with higher levels indicating greater inflammation and organ damage. NAg may help identify infected patients at an increased risk of severe COVID-19 and ensure their admission to the most appropriate level of care. KL-6 may help predict interstitial lung damage and the severity of clinical features. Further studies are needed to establish a decision-making cut-off for these biomarkers in COVID-19.

Keywords: COVID-19 pneumonia; Krebs von del Lungen-6; SARS-CoV-2 nucleocapsid antigen.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Positive Pearson correlation between NAg levels and CRP, PCT, IL-6, and TSS values.
Figure 2
Figure 2
Positive Pearson correlation between KL-6 levels and NAg, TSS values.
Figure 3
Figure 3
Positive Pearson correlation between TSS levels and IL-6, CRP, and IL-2R values.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sharma A., Farouk I.A., Lal S.K., Martinez-Sobrido L., Toral F.A. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021;13:202. doi: 10.3390/v13020202. - DOI - PMC - PubMed
    1. Nigro E., Perrotta F., Polito R., D’Agnano V., Scialò F., Bianco A., Daniele A. Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways. Int. J. Endocrinol. 2020;2020:8896536. doi: 10.1155/2020/8896536. - DOI - PMC - PubMed
    1. Palladino R., Mercogliano M., Fiorilla C., Frangiosa A., Iodice S., Sanduzzi Zamparelli S., Montella E., Triassi M., Sanduzzi Zamparelli A. Association between COVID-19 and Sick Leave for Healthcare Workers in a Large Academic Hospital in Southern Italy: An Observational Study. Int. J. Environ. Res. Public Health. 2022;19:9670. doi: 10.3390/ijerph19159670. - DOI - PMC - PubMed
    1. Khalid M.F., Selvam K., Jeffry A.J.N., Salmi M.F., Najib M.A., Norhayati M.N., Aziah I. Performance of Rapid Antigen Tests for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis. Diagnostics. 2022;12:110. doi: 10.3390/diagnostics12010110. - DOI - PMC - PubMed
    1. Sanduzzi A., Zamparelli S.S. Nasopharyngeal and Oropharyngeal Swabs, And/Or Serology for SARS COVID-19: What Are We Looking For? Int. J. Environ. Res. Public Health. 2020;17:3289. doi: 10.3390/ijerph17093289. - DOI - PMC - PubMed

Grants and funding

This research received no external funding.